Physician

Eric Thomas, MD

According to 2025 Medicare claims, Eric Thomas, MD (NPI: 1881915940) practices gynecologist/oncologist in the Tulsa, OK market, with the plurality of this provider's patient population coming from Tulsa, OK. This provider's primary affiliated billing organization is OKLAHOMA CANCER SPECIALISTS AND RESEARCH INSTITUTE LLC (NPI: 1962876045; TIN: 383983999) and primary practice location at 74146-6236. Thomas is affiliated with the Lifecare ACO LLC (ACO ID: A3644), participating under the MSSP model.

Thomas' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 535 traditional Medicare patients, billed 119,656 HCPCS/CPT codes, and received $2,218,048 in Medicare payments. The top billing code was 96413 (Administration of chemotherapy into vein, 1 hour or less). Part D data shows 867 prescription claims across 166 beneficiaries totaling $1,305,627 in drug costs, led by Zejula (Niraparib Tosylate). Open Payments data shows 17 records totaling $1,113. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $3,657 to $2,218,048. Similarly, Part D prescription costs have risen steadily, from $316 to $1,305,627. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.1M$2.2M2015 Medicare payment: $3,657 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $7,884 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $320,104 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $1,377,130 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $1,286,973 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $1,296,796 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $1,313,701 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $1,173,135 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $1,434,250 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $2,218,048 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20152128$3,657
20164260$7,884
201715324,303$320,104
2018558107,849$1,377,130
201953686,103$1,286,973
202051570,613$1,296,796
2021653104,186$1,313,701
202250578,491$1,173,135
202343386,171$1,434,250
2024535119,656$2,218,048

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$653K$1.3M2016 Drug cost: $316 (USD; Tot_Drug_Cst)2017 Drug cost: $1,289 (USD; Tot_Drug_Cst)2018 Drug cost: $24,352 (USD; Tot_Drug_Cst)2019 Drug cost: $150,287 (USD; Tot_Drug_Cst)2020 Drug cost: $132,888 (USD; Tot_Drug_Cst)2021 Drug cost: $288,779 (USD; Tot_Drug_Cst)2022 Drug cost: $433,355 (USD; Tot_Drug_Cst)2023 Drug cost: $627,832 (USD; Tot_Drug_Cst)2024 Drug cost: $1,305,627 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
20161113$316
20173462$1,289
2018127373$24,352
2019136404$150,287
2020136475$132,888
2021141599$288,779
2022165714$433,355
2023167760$627,832
2024166867$1,305,627

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
96413Administration of chemotherapy into vein, 1 hour or less135265$88
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more89143$86
96367Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less110329$19
96372Injection of drug or substance under skin or into muscle95166$10
J1100Injection, dexamethasone sodium phosphate, 1 mg941,911$0

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
ZejulaNiraparib Tosylate421,260$758,974
LenvimaLenvatinib Mesylate16480$381,725
LynparzaOlaparib12360$142,855
Megestrol AcetateMegestrol Acetate26690$1,677
Clobetasol PropionateClobetasol Propionate16363$790

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.17$1,113Baxter Healthcare
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Eric Thomas, MD?

Tedicare shows public-source Medicare data for Eric Thomas, MD (NPI 1881915940), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Eric Thomas, MD have ACO affiliation data?

Eric Thomas, MD is shown with ACO affiliation data for Lifecare ACO LLC (MSSP, ACO ID A3644).

What billing organization is linked to Eric Thomas, MD?

Eric Thomas, MD is linked to OKLAHOMA CANCER SPECIALISTS AND RESEARCH INSTITUTE LLC (billing NPI 1962876045) in the available physician profile data.

Does Eric Thomas, MD have Open Payments data?

Eric Thomas, MD has 17 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.